Blastx
Payments companies reported to CMS as associated with Blastx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Blastx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Blastx
These are the largest totals companies reported as associated with Blastx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Patricia Stevenson | Skiatook, OK | Registered Nurse | $347,882.47 |
| Matthew Regulski | Toms River, NJ | Foot & Ankle Surgery | $191,901.78 |
| Ravi Bashyal | Skokie, IL | Orthopaedic Surgery | $94,511.03 |
| Robert Nemerofsky | Denville, NJ | Plastic Surgery | $3,534.50 |
| Berdj Stepanian | White Plains, NY | Foot Surgery | $3,501.76 |
| Joseph Larsen | Garden City Park, NY | Foot & Ankle Surgery | $3,107.80 |
| Rick Delmonte | New York, NY | Foot Surgery | $1,377.02 |
| Jon Minter | Alpharetta, GA | Orthopaedic Surgery | $1,340.11 |
| Earl Ferguson | San Antonio, TX | Plastic Surgery | $1,286.46 |
| Robert Hoover | Lake Mary, FL | Podiatrist | $1,268.21 |
Prescribed Blastx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.